Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 893 items.
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
AlertHealth professional risk communication | 2024-06-07
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
AlertHealth professional risk communication | 2024-06-05
Jamp Digoxin tablet: Over-sized tablet
RecallHealth product recall | 2024-06-03
Octaplasma solution: exposed to temperatures outside of the recommended storage conditions
RecallHealth product recall | 2024-06-03
Extra Strength Heartburn Relief; Foreign matter
RecallHealth product recall | 2024-05-29
Probiotic antibiotic support capsule: Out-of-specification (Bacterial content)
RecallHealth product recall | 2024-05-27
Swical-Energy Extra-Strength Liquid: Incorrect expiry date
RecallHealth product recall | 2024-05-27
Tisseel Kit; Out-of-specification (Dissolution)
RecallHealth product recall | 2024-05-23
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
RecallHealth product recall | 2024-05-16
REDDY-SAPROPTERIN: Color change & decrease potency
RecallHealth product recall | 2024-05-03
Importation of Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules due to the Current Shortage of Canadian-authorized Cisatracurium Omega
AlertHealth professional risk communication | 2024-04-24
Miracle Reds: missing risk statement
RecallHealth product recall | 2024-04-23
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17